The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant atezolizumab + chemotherapy in resectable non-small cell lung cancer (NSCLC).
 
Catherine A. Shu
Consulting or Advisory Role - Genentech/Roche
 
Claud Grigg
No Relationships to Disclose
 
Codruta Chiuzan
No Relationships to Disclose
 
Robert F. Garofano
No Relationships to Disclose
 
Vijeta Patel
No Relationships to Disclose
 
Susana Hernandez
No Relationships to Disclose
 
Tiffany Negri
No Relationships to Disclose
 
Adrian G. Sacher
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Gritstone Bio; Pfizer
 
Stephanie Smith-Marrone
No Relationships to Disclose
 
Mark Stoopler
No Relationships to Disclose
 
Justin F. Gainor
Honoraria - ARIAD; Incyte; Merck; Novartis; Pfizer
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Genentech; Loxo; Takeda; Theravance
Research Funding - Adaptimmune (Inst); ARIAD; AstraZeneca (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Genentech; Jounce Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Affymetrix
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Foundation Medicine; Genentech; Merck; Nektar; Novartis; Pfizer; Syndax
Research Funding - Bristol-Myers Squibb
 
Frank D'Ovidio
No Relationships to Disclose
 
Joshua R. Sonett
No Relationships to Disclose
 
Matthew Bacchetta
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
 
Anjali Saqi
Honoraria - Medscape
Consulting or Advisory Role - Boston Scientific; Genentech/Roche
Patents, Royalties, Other Intellectual Property - I have a patent for a cell block device. The technology has been licensed through Columbia University to a company. I received royalties.
Travel, Accommodations, Expenses - Boston Scientific
 
Naiyer A. Rizvi
Leadership - ARMO BioSciences
Stock and Other Ownership Interests - ARMO BioSciences; Gritstone Bio
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Janssen; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Regeneron